Take charge of your SAA

PROMACTA® (eltrombopag) is the first and only platelet booster approved to treat severe aplastic anemia.

Important Safety Information, including Boxed WARNING:

 

What is the most important information I should know about PROMACTA?

PROMACTA can cause serious side effects, including:

Liver problems.

PROMACTA may increase your risk of liver problems that may be ...

See More

Approved Uses and Important Safety Information

Approved Uses for PROMACTA® (eltrombopag)

PROMACTA is a prescription medicine used to treat people with severe aplastic anemia (SAA) in combination with standard immunosuppressive therapy as the first treatment for adults and children 2 years of age and older. PROMACTA is also used to treat your SAA when other medicines have not worked well...

See More
LEARN MORE ABOUT

PROMACTA

Learn more about PROMACTA, the first and only once-daily oral treatment option for severe aplastic anemia (SAA). Your doctor may consider PROMACTA as your first treatment, or after other therapies have stopped working.
Learn More
LEARN MORE ABOUT

PATIENT SUPPORT

Find the support you need, from downloadable materials to co-pay and access programs and financial assistance. Sign up for PROMACTA4U to receive the latest updates and information.

LEARN MORE